High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients

Rivero‐Juárez, Antonio; Martinez-Dueñas, Loreto; Martínez-Peinado, Antonio; Camacho, Ángela; Cifuentes, Celia; Gordon, Ana; Frías, Mario; Torre‐Cisneros, Julián; Pineda, Juan A.

doi:10.1016/j.jinf.2014.10.016

Cited by 28 publications

(36 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 We found an HEV seroprevalence of 9.8% [95% CI: 8.02%e11.9%]. 1 We found an HEV seroprevalence of 9.8% [95% CI: 8.02%e11.9%].…”

Section: Absence Of Occult Hepatitis E Virus Infection Among Hiv Immumentioning

confidence: 76%

See 1 more Smart Citation

Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients

Martinez-Dueñas¹,

Martínez-Peinado²,

Camacho³

et al. 2015

Journal of Infection

Self Cite

View full text Add to dashboard Cite

“…1 We found an HEV seroprevalence of 9.8% [95% CI: 8.02%e11.9%]. 1 We found an HEV seroprevalence of 9.8% [95% CI: 8.02%e11.9%].…”

Section: Absence Of Occult Hepatitis E Virus Infection Among Hiv Immumentioning

confidence: 76%

“…The details of the baseline characteristics are summarized in Table 1. 1 This patient also exhibited seropositivity to IgM anti-HEV. The remaining 86 patients were classified as seronegative.…”

Section: Absence Of Occult Hepatitis E Virus Infection Among Hiv Immumentioning

confidence: 82%

Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients

Martinez-Dueñas¹,

Martínez-Peinado²,

Camacho³

et al. 2015

Journal of Infection

Self Cite

View full text Add to dashboard Cite

“…In Europe, reported seroprevalence among HIV ranges from 1% to 26% [52, 258–265] with some countries, for example, Spain, with values ranging from 9 to 26% depending on the study [52, 53, 259, 260, 266–268]. According to some authors, HIV infection seems to be a risk factor, not for acquiring an HEV infection, but for developing a chronic infection.…”

Section: Routes Of Transmission and Risk Groupsmentioning

confidence: 99%

Hepatitis E Virus in Industrialized Countries: The Silent Threat

Clemente-Casares

Ramos-Romero

Ramirez-Gonzalez

et al. 2016

BioMed Research International

View full text Add to dashboard Cite

Hepatitis E virus (HEV) is the main cause of acute viral hepatitis worldwide. Its presence in developing countries has been documented for decades. Developed countries were supposed to be virus-free and initially only imported cases were detected in those areas. However, sporadic and autochthonous cases of HEV infection have been identified and studies reveal that the virus is worldwide spread. Chronic hepatitis and multiple extrahepatic manifestations have also been associated with HEV. We review the data from European countries, where human, animal, and environmental data have been collected since the 90s. In Europe, autochthonous HEV strains were first detected in the late 90s and early 2000s. Since then, serological data have shown that the virus infects quite frequently the European population and that some species, such as pigs, wild boars, and deer, are reservoirs. HEV strains can be isolated from environmental samples and reach the food chain, as shown by the detection of the virus in mussels and in contaminated pork products as sausages or meat. All these data highlight the need of studies directed to control the sources of HEV to protect immunocompromised individuals that seem the weakest link of the HEV epidemiology in industrialized regions.

show abstract

“…[6][7][8][9] In our neighbor countries, Pischke et al found anti-HEV positivity of 4.9%, whereas Balayan et al reported the value of 11.1% in German and Russian HIV-infected patients, respectively. 10,11 In BDs, the HEV seroprevalence assessed with the use of highly-sensitive tests varied from 4.7% in Scotland to 52.5% in the hyper-endemic area of south-western France.…”

Section: Discussionmentioning

confidence: 75%

“…The current study has several limitations: first, the number of the tested participants was relatively low; second, the upper value of the age range (55 years; due to the age profile of BDs) could, at least partially, influence the HEV seroprevalence data in terms of the lower frequency of anti-HEV in younger individuals reported by many other authors; 9,21,23 third, no HEV-RNA detection was performed in this study. Although HEV-RNA positivity is infrequent in asymptomatic inhabitants of Western countries, it is the direct indicator of potential risks related to HEV infection (chronic hepatitis E in HIV patients and transfusion-related risk for immunocompromised recipients of blood products).…”

Section: Discussionmentioning

confidence: 84%

Hepatitis E virus antibodies in HIV-infected patients and blood donors from western Poland - a preliminary report

Bura¹,

Bukowska²,

Bura³

et al. 2017

Adv Clin Exp Med

View full text Add to dashboard Cite

show abstract

High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients

Cited by 28 publications

References 27 publications

Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients

Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients

Hepatitis E Virus in Industrialized Countries: The Silent Threat

Hepatitis E virus antibodies in HIV-infected patients and blood donors from western Poland - a preliminary report

Contact Info

Product

Resources

About